[Federal Register Volume 75, Number 107 (Friday, June 4, 2010)]
[Notices]
[Pages 31795-31796]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-13484]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities; Recombinant DNA Research: 
Amended Notice of Meeting

ACTION: Notice of cancellation of consideration of a proposed action

[[Page 31796]]

under Section III-A-1 of the NIH Guidelines for Research Involving 
Recombinant DNA Molecules (NIH Guidelines).

-----------------------------------------------------------------------

SUMMARY: Notice of a discussion of a proposed action under Section III-
A-1 published on May 24, 2010 (75 FR 28811) is withdrawn. The 
discussion that was to be held at the June 16-17, 2010 meeting of the 
NIH Recombinant DNA Advisory Committee has been deferred at the request 
of the principal investigator.

FOR FURTHER INFORMATION CONTACT: OBA by e-mail at [email protected], or 
telephone at 301-496-9838, if you have questions, or require additional 
information.

    Dated: May 26, 2010.
Jacqueline Corrigan-Curay,
Acting Director, Office of Biotechnology Activities, National 
Institutes of Health.
[FR Doc. 2010-13484 Filed 6-3-10; 8:45 am]
BILLING CODE 4140-01-P